尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Discover the complete record of transactions filed by Krishnan Mahesh. Insider active across 2 companies, notably Chinook Therapeutics, INC.. Cumulatively, 6 disclosures have been recorded. Split: 0 buy · 1 sell. Activity tracked since 25 April 2024. The latest transaction was disclosed on 1 May 2025 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 条申报中的 6 条
Krishnan Mahesh is a declarant linked to Halozyme Therapeutics, INC. and Chinook Therapeutics, INC., where he is listed as Director. The record shows 6 filings in total, and the recent filings covered run from 2023-04-04 to 2026-06-30. The modal transaction nature is Option exercise, and the cumulative buy and sell amounts for the recent sample are both 0.